Serum resistance associated with virulence in Yersinia enterocolitica.

PubWeight™: 3.37‹?› | Rank: Top 1%

🔗 View Article (PMC 351084)

Published in Infect Immun on February 01, 1982

Authors

C H Pai, L DeStephano

Articles citing this

Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun (1984) 6.63

Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70

In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun (1984) 4.16

Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81

Vwa+ phenotype of Yersinia enterocolitica. Infect Immun (1983) 3.72

Plasmid-mediated and temperature-regulated surface properties of Yersinia enterocolitica. Infect Immun (1983) 3.13

Virulence plasmid-associated autoagglutination in Yersinia spp. J Bacteriol (1984) 3.01

Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination. Infect Immun (1985) 2.81

Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut (1990) 2.54

Differentiation between virulent and avirulent Yersinia enterocolitica isolates by using Congo red agar. J Clin Microbiol (1983) 2.52

Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43

Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42

Assay of crystal violet binding for rapid identification of virulent plasmid-bearing clones of Yersinia enterocolitica. J Clin Microbiol (1987) 2.20

Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun (1995) 1.92

Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica. Proc Natl Acad Sci U S A (1992) 1.90

Evaluation of virulence factor testing and characteristics of pathogenicity in Yersinia enterocolitica. Infect Immun (1983) 1.76

Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72

A novel virulence-associated cell surface structure composed of 47-kd protein subunits in Yersinia enterocolitica. EMBO J (1985) 1.68

T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect Immun (1992) 1.66

Thermoregulation-dependent expression of Yersinia enterocolitica protein 1 imparts serum resistance to Escherichia coli K-12. J Bacteriol (1989) 1.66

Expression of antigens encoded by the virulence plasmid of Yersinia enterocolitica under different growth conditions. Infect Immun (1985) 1.64

Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect Immun (1992) 1.61

Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect Immun (1986) 1.57

Determination of plasmid-associated hydrophobicity of Yersinia enterocolitica by a latex particle agglutination test. J Clin Microbiol (1984) 1.54

Plasmid-associated cell surface charge and hydrophobicity of Yersinia enterocolitica. Infect Immun (1984) 1.52

Clinical significance of virulence-related assay of Yersinia species. J Clin Microbiol (1987) 1.46

In vitro assessment of virulence in Yersinia enterocolitica and related species. J Clin Microbiol (1985) 1.45

Virulence factors of Haemophilus ducreyi. Infect Immun (1984) 1.41

Association of fibril structure formation with cell surface properties of Yersinia enterocolitica. Infect Immun (1984) 1.39

Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis (1994) 1.38

Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog (2008) 1.36

Expression of invasin and motility are coordinately regulated in Yersinia enterocolitica. J Bacteriol (1998) 1.35

Binding of Yersinia enterocolitica to rabbit intestinal brush border membranes, mucus, and mucin. Infect Immun (1989) 1.33

Humoral and cellular defense against intestinal murine infection with Yersinia enterocolitica. Infect Immun (1991) 1.28

Simple method for demonstration of differential colony morphology of plasmid-associated virulent clones of Yersinia enterocolitica. J Clin Microbiol (1983) 1.23

Transfusion-associated bacterial sepsis. Clin Microbiol Rev (1994) 1.22

Clonal diversity and relationships among strains of Yersinia enterocolitica. J Clin Microbiol (1989) 1.17

In vitro and in vivo characterization of an ail mutant of Yersinia enterocolitica. Infect Immun (1995) 1.08

Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica. Infect Immun (1989) 1.03

Growth in and breakdown of purified rabbit small intestinal mucin by Yersinia enterocolitica. Infect Immun (1993) 0.97

Binding of Yersinia enterocolitica to purified, native small intestinal mucins from rabbits and humans involves interactions with the mucin carbohydrate moiety. Infect Immun (1994) 0.96

Serum resistance of Yersinia enterocolitica expressed in absence of other virulence markers. Infect Immun (1983) 0.93

Comparison of three tests for virulent Yersinia enterocolitica. J Clin Microbiol (1984) 0.92

Adhesion of Yersinia enterocolitica to purified rabbit and human intestinal mucin. Infect Immun (1993) 0.91

Avidity of antibodies against released proteins of Yersinia spp: comparison of patients with or without reactive arthritis. Ann Rheum Dis (1989) 0.87

Identification of a conjunctivitis-associated gene locus from the virulence plasmid of Yersinia enterocolitica. Infect Immun (1990) 0.86

Role of antibodies in the opsonization of Yersinia spp. Infect Immun (1988) 0.85

Serum opsonic capacity against Yersinia enterocolitica O:3 in yersiniosis patients with or without reactive arthritis. Clin Exp Immunol (1989) 0.78

Class-specific immune response to Yersinia enterocolitica serotype O9 antigens as determined by enzyme-linked immunosorbent assay. J Clin Microbiol (1991) 0.76

Spontaneous Yersinia enterocolitica septicemia in a patient with iron overload. Can J Infect Dis (1990) 0.75

Expression, purification, and characterization of the humoral immune response to recombinant MyfA protein of Yersinia enterocolitica. Eur J Clin Microbiol Infect Dis (2009) 0.75

Articles cited by this

Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun (1981) 13.80

Experimental shigella keratoconjunctivitis; a preliminary report. Acta Microbiol Acad Sci Hung (1955) 11.91

Plasmid associated with pathogenicity and calcium dependency of Yersinia enterocolitica. Infect Immun (1980) 11.90

The basis of virulence in Pasteurella pestis: an antigen determining virulence. Br J Exp Pathol (1956) 8.78

Plasmid-mediated tissue invasiveness in Yersinia enterocolitica. Nature (1980) 8.15

Presence of a virulence-associated plasmid in Yersinia pseudotuberculosis. Infect Immun (1980) 7.55

Correlation of autoagglutination and virulence of yersiniae. J Clin Microbiol (1980) 6.85

Yersinia enterocolitica: a panoramic view of a charismatic microorganism. CRC Crit Rev Microbiol (1977) 6.66

The genus Yersinia: biochemistry and genetics of virulence. Curr Top Microbiol Immunol (1972) 6.32

Plasmids in Yersinia pestis. Infect Immun (1981) 6.22

Pathogenecity of Yersinia enterocolitica for mice. Infect Immun (1975) 5.50

BIOSYNTHESIS AND PURIFICATION OF V AND W ANTIGEN IN PASTEURELLA PESTIS. J Immunol (1963) 5.05

Plague virulence antigens from Yersinia enterocolitica. Infect Immun (1980) 4.83

Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94

The ability of some Yersinia enterocolitica strains to invade HeLa cells. Can J Microbiol (1977) 3.87

Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. Nature (1979) 3.18

Studies on the pathogenicity of Yersinia enterocolitica. I. Experimental infection in rabbits. Microbiol Immunol (1977) 2.99

THE EFFECT OF CA++ AND MG++ ON LYSIS, GROWTH, AND PRODUCTION OF VIRULENCE ANTIGENS BY PASTEURELLA PESTIS. J Infect Dis (1964) 2.98

Studies on the pathogenicity of Yersinia enterocolitica. II. Interaction with cultured cells in vitro. Microbiol Immunol (1977) 2.96

Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73

Pathologic features of enteric infection with Yersinia enterocolitica. Arch Pathol (1974) 2.13

Prevalence of enterotoxigenicity in human and nonhuman isolates of Yersinia enterocolitica. Infect Immun (1978) 2.04

Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99

Yersinia enterocolitica infections in children. J Pediatr (1976) 1.89

Methodology for recognition of invasive potential of Escherichia coli. J Assoc Off Anal Chem (1977) 1.65

Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59

Detection of enterotoxigenic and invasive strains of Yersinia enterocolitica. Contrib Microbiol Immunol (1979) 1.38

A protein factor associated with serum resistance in Escherichia coli. J Med Microbiol (1977) 1.29

[Experimental pathogenicity of "Yersinia enterocolitica" for athymic nude mice (author's transl)]. Ann Microbiol (Paris) (1975) 1.22

An experimental study of the pathology and ecology of Yersinia enterocolitica infection in mice. Contrib Microbiol Immunol (1979) 1.05

Articles by these authors

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med (1984) 6.54

Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94

Campylobacter gastroenteritis in children. J Pediatr (1979) 3.42

Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. AIDS (1989) 3.19

Detection of Salmonella typhi in the blood of patients with typhoid fever by polymerase chain reaction. J Clin Microbiol (1993) 3.08

Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis (1999) 2.74

Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73

Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun (1986) 2.64

Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59

Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica. Infect Immun (1987) 2.43

Vancomycin-intermediate Staphylococcus aureus in Korea. J Clin Microbiol (2000) 2.16

Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13

Prevalence of enterotoxigenicity in human and nonhuman isolates of Yersinia enterocolitica. Infect Immun (1978) 2.04

Experimental Yersinia enterocolitica enteritis in rabbits. Infect Immun (1980) 1.99

Inhibition of human neutrophil chemiluminescence by plasmid-mediated outer membrane proteins of Yersinia enterocolitica. Infect Immun (1985) 1.72

Invasiveness of Yersinia enterocolitica lacking the virulence plasmid: an in-vivo study. J Med Microbiol (1987) 1.62

Pathogenic properties of Yersinia enterocolitica. Infect Immun (1980) 1.59

Biosynthesis of biotin in microorganisms. VI. Further evidence for desthiobiotin as a precursor in Eschericia coli. J Bacteriol (1967) 1.50

Biosynthesis of biotin in microorganisms. IV. Repression and derepression of (+ -)-biotin synthesis from (+)-desthiobiotin. Arch Biochem Biophys (1966) 1.42

Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39

The histopathology of rectosigmoid biopsies from adults with bloody diarrhea due to verotoxin-producing Escherichia coli. Am J Clin Pathol (1987) 1.29

Biosynthesis of desthiobiotin in cell-free extracts of Escherichia coli. J Bacteriol (1969) 1.19

Risk factors for Escherichia coli O157:H7 infection in an urban community. J Infect Dis (1989) 1.18

Nosocomial infantile gastroenteritis associated with minirotavirus and calicivirus. J Pediatr (1978) 1.18

Biosynthesis of biotin in microorganisms. V. Control of vitamer production. J Bacteriol (1967) 1.17

Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci (1992) 1.12

Enhancement of recovery of Neisseria meningitidis by gelatin in blood culture media. J Clin Microbiol (1981) 1.12

Rapid diagnosis of rotavirus gastroenteritis by a commercial latex agglutination test. J Clin Microbiol (1985) 1.12

Chromosomal location of mutations affecting the regualtion of biotin synthesis in Escherichia coli. Can J Microbiol (1975) 1.11

Mutant of Escherichia coli with derepressed levels of the biotin biosynthetic enzymes. J Bacteriol (1972) 1.10

Biosynthesis of biotin: synthesis of 7,8-diaminopelargonic acid in cell-free extracts of Escherichia coli. J Bacteriol (1971) 1.06

Spread of multidrug-resistant Streptococcus pneumoniae in South Korea. Clin Infect Dis (1997) 1.05

Partial purification and properties of D-desthiobiotin synthetase from Escherichia coli. J Bacteriol (1970) 1.04

Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial Infection Surveillance Committee of the Korean Society for Nosocomial Infection Control. Am J Infect Control (2000) 1.03

In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother (1978) 1.02

Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 0.99

Genetics of biotin biosynthesis in Bacillus subtilis. J Bacteriol (1975) 0.99

Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. J Pediatr (1984) 0.98

Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child (1983) 0.97

Simple screening method for beta-lactamase-positive and -negative ampicillin-resistant Haemophilus influenzae isolates. J Clin Microbiol (1984) 0.94

Biotin uptake in biotin regulatory mutant of Escherichia coli. J Bacteriol (1973) 0.94

Detection of the H1-j strain of Salmonella typhi among Korean isolates by the polymerase chain reaction. Am J Trop Med Hyg (1994) 0.93

Effect of shock wave therapy on acute fractures of the tibia: a study in a dog model. Clin Orthop Relat Res (2001) 0.91

Model of neonatal meningitis caused by Escherichia coli K1 in guinea pigs. J Infect Dis (1980) 0.90

Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol (1996) 0.87

Uptake of pimelic acid by Escherichia coli and Pseudomonas denitrificans. Can J Microbiol (1969) 0.85

Short-course doxycycline treatment versus conventional tetracycline therapy for scrub typhus: a multicenter randomized trial. Clin Infect Dis (1995) 0.85

Biochemical and genetic characterization of dehydrobiotin resistant mutants of Escherichia coli. Mol Gen Genet (1974) 0.84

Pasteurella ureae meningoencephalitis. J Pediatr (1978) 0.83

In situ enzyme immunoassay for antiviral susceptibility testing of respiratory syncytial virus. Am J Clin Pathol (1989) 0.83

Effect of acute Yersinia enterocolitica infection on in vivo and in vitro small intestinal solute and fluid absorption in the rabbit. Gastroenterology (1988) 0.82

Treatment of candidal diaper dermatitis: a double-blind placebo-controlled comparison of topical nystatin with topical plus oral nystatin. J Pediatr (1982) 0.81

Rotavirus gastroenteritis. J Diarrhoeal Dis Res (1990) 0.81

Penetration of the intestinal mucosa by Yersinia enterocolitica lacking the virulence plasmid. Contrib Microbiol Immunol (1987) 0.81

Replication of cytomegalovirus in human thymic epithelial cells. Med Microbiol Immunol (1989) 0.79

In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea. Yonsei Med J (2000) 0.78

Anti-phagocytic role of plasmid-associated outer membrane proteins of Yersinia enterocolitica. Contrib Microbiol Immunol (1987) 0.77

Colonic function in acute Yersinia enterocolitica infection in rabbits. Clin Invest Med (1988) 0.77

Yersinia enterocolitica infection in children: 4 years experience in the Montreal urban community. Contrib Microbiol Immunol (1979) 0.76

Sepsis and cholestasis: the in vitro effects of bacterial products on 14C-taurocholate uptake by isolated rat hepatocytes. Liver (1986) 0.76

Yersinia enterocolitica: mechanisms of microbial pathogenesis and pathophysiology of diarrhoea. J Gastroenterol Hepatol (1991) 0.76

Rotazyme test in neonates. J Pediatr (1985) 0.75

Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae. Chemotherapy (2000) 0.75

Infection due to Yersinia enterocolitica in children with abdominal pain. J Infect Dis (1982) 0.75

Rhodococcus equi pneumonia in a heart transplant recipient in Korea, with emphasis on microbial diagnosis. Clin Microbiol Infect (2003) 0.75